MICROBIOLOGICAL CHARACTERISATION OF Haemophilus influenzae STRAINS ISOLATED FROM PATIENTS WITH INVASIVE AND RESPIRATORY DISEASES by Tomislav Kostyanev et al.
66  / JofIMAB; Issue: vol. 16, book 3, 2010 /
MICROBIOLOGICAL CHARACTERISATION OF
HAEMOPHILUS INFLUENZAE STRAINS
ISOLATED FROM PATIENTS WITH INVASIVE AND
RESPIRATORY DISEASES
Kostyanev T.*, L. Setchanova, V. Ouzounova-Raykova, Y. Proevska, I. Mitov
Department of Medical Microbiology, Faculty of Medicine,
Medical University - Sofia, Bulgaria
Journal of IMAB - Annual Proceeding (Scientific Papers) vol. 16, book 3, 2010
SUMMARY
A total of 175 H. influenzae strains were collected
between 1994 and 2009 from all aged patient groups. The
strains were isolated from patients with invasive and
community-acquired respiratory tract infections. All strains
were identified according to standard microbiological
methods. Serotyping was done by a coagglutination test
and by molecular PCR capsular genotyping. Beta-lactamase
production was determined by the chromogenic
cephalosporin test with nitrocephin as substrate.
Most of the isolated H. influenzae strains were from
children under 5 years of age (57.7%). Overall, 61 strains
belonged to serotype b (34.9%) by the means of PCR
capsular typing, 1 strain was type f, and 113 isolates (64.6%)
were non-typeable (non-encapsulated) H. influenzae. Among
the infants and children with meningitis or other invasive
infections, aged 2 month to 5 years, all strains, except one,
were serotype b. In respiratory tract infections (pneumonia,
otitis media, sinusitis and people with chronic pulmonary
diseases - exacerbations of COPD, bronchiectasis, cystic
fibrosis) the most common - 96.5% were non-typeable
strains in both groups children and adults. Overall, the
prevalence of beta-lactamase production was 19.4%. But, it
was much higher for invasive strains from CSF isolates -
37.7%, 25% in blood samples, and 37.5% in otitis media
causative strains. Beta-lactamase production was less
frequent in respiratory tract isolates - in sputum 13.3% and
in URT samples - 2.3%. The rate of beta-lactamase
production in CSF isolates has not changed for the last 10
years.
PCR capsular genotyping method has to be
performed for all non-b-type strains. The implementation of
Hib vaccine in our country will be accompanied by a
reduction in invasive diseases caused by H. influenzae type
b in children, but it is not useful in preventing infections
caused by non-typeable H. influenzae strains.
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INTRODUCTION
Haemophilus influenzae is one of the leading
bacterial agents, causing community-acquired invasive and
respiratory diseases in both children and adults.
New H. influenzae type b conjugate vaccine (Hib) is
now available. Bulgarian Ministry of Health decided to
introduce vaccination against Hib disease in our childhood
vaccination schedule starting in April 2010.
The aims of this study were:
1. To determine different capsular types by PCR
genotyping of H. influenzae strains isolated from children
and adults with invasive and respiratory diseases before the
introduction of Hib conjugate vaccine in our country.
2. To study the microbiological features of the
collected isolates: beta-lactamase production; biotypes and
other clinical parameters.
MATERIALS AND METHODS
Bacterial isolates. A total of 175 H. influenzae strains
were collected between 1994 and 2009 from all aged groups.
They were isolated from cerebrospinal fluid (CSF) (n=53),
blood (n=8), sputum (n=60), ear fluid (n=8) and upper
respiratory tract (URT) (n=46). Patients from whom the
strains were isolated had meningitis, septicemia or
community-acquired respiratory tract infections (otitis media
in children, pneumonia, bronchitis, conjunctivitis or acute
exacerbations of chronic obstructive pulmonary disease in
adults).
All strains were identified according to the standard
microbiological methods [4]. Beta-lactamase production was
determined by the chromogenic cephalosporin test with
nitrocephin as substrate (Cefinase, BBL, BD).
Serotyping of H.influenzae. The strains were
serotyped by a coagglutination test (Phadebact
Haemophilus test; Bactus AB, Huddinge, Sweden) and by
molecular PCR capsular typing method.
DNA isolation. DNA isolation was performed from a
24-hour culture on chocolate agar containing 1% isovitalex.
One loopful of each bacterial culture was suspended in 400
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boiling extract was centrifuged at 12,000 x g for 10 min. The
supernatant was then collected.
PCR of capsular genes. The genes were amplified with
primer sets by Falla et al. [2] and listed in Table 1. PCR was
implemented by using 2.5 µl of template DNA, 1 µM of each
primer, 0.2 mM deoxyribonucleotides, 1 x reaction buffer, 2
mM MgCl2 and 0,5 U of Taq polymerase in a total volume of
25 µl.  The DNA was amplified using the following protocol:
initial denaturation (94°C for 5 min), followed by 25 cycles of
denaturation (94°C for 1 min), annealing (60°C for 1 min), and
extension (72°C for 1 min). After the final cycle there was a
single final extension of 10 min at 72°C. 10 µl of PCR products
were separated for 30 min at 130 V in 1% agarose in Tris-Cl-
borate-EDTA buffer and visualized by ethidium bromide
staining (0.5 ìg/ml). The size of the amplified products was
compared with a positive control, obtained from CDC, Atlanta,
USA. The detection was performed by UV transillumination
(wavelength 312 nm).
Table 1. Capsule type-specific PCR primers
a to f HI-1 CGT TTG TAT GAT GTT GAT CCA GAC
HI-2 TGT CCA TGT CTT CAA AAT GAT G
a a1 CTA CTC ATT GCA GCA TTT GC
a2 GAA TAT GAC CTG ATC TTC TG
b b1 GCG AAA GTG AAC TCT TAT CTC TC
b2 GCT TAC GCT TCT ATC TCG GTG AA
c c1 TCT GTG TAG ATG ATG GTT CA
c2 CAG AGG CAA GCT ATT AGT GA
d dl TGA TGA CCG ATA CAA CCT GT
d2 TCC ACT CTT CAA ACC ATT CT
e e1 GGT AAC GAA TGT AGT GGT AG
e2 GCT TTA CTG TAT AAG TCT AG
f f1 GCT ACT ATC AAG TCC AAA TC
f2 CGC AAT TAT GGA AGA AAG CT
RESULTS AND DISCUSSION
Taking in consideration the specimens’ source of
isolates and the patients’ age, it was obvious that the
meningitis and other invasive diseases were the most
common (91.8%) in children less than 5 years of age (56 out
of 61 cases) and they were caused predominantly by serotype
b of H. influenzae (95.1%).
Alternatively, in respiratory tract infections (RTI-114
cases), 39.5% of the isolates were from children under the
age of 5 years and 48.2% were from adult patients. (Fig. 1)
Serotype PCR determination was performed in two
steps and it characterized all 175 H. influenzae strains as
follows: 61 (34.9%) strains were type b, 1 (0.6%) isolate type
f, and the rest 113 (64.6%) strains were non-capsulated or non-
typeable H. influenzae (NTHi). (Fig. 2) The first set of primers
(HI1 and HI2) amplified a 343 bp product only from the 62
capsulate strains (Fig. 3). All the others, previously serotyped
by the coagglutination test, were negative for the capsular
expression gene (bexA) and hence, non-capsulated. The
second set of primers (b1 and b2) used, revealed a 480 bp
product from all the capsulate strains but one (Fig. 4). They
were clearly confirmed as H. influenzae type b, possessing
duplicated capB locus. The second primers’ set was also used
to verify whether all NC strains are really lacking capsular
genes or amongst these there are so called mutant b¯ strains.
These strains are indistinguishable from NC strains by
traditional serotyping techniques but can be determined by
the PCR method. As a result of losing one of the copies of
the cap gene and the bexA gene they fail to produce and
express a capsule. They can be detected after amplification
with b1 and b2 primers, producing type b-specific product.
All the 113 strains which failed to produce product with HI-1
and HI-2, were also negative with b1 and b2 which excluded
the presence of capsule-deficient mutants among the isolates.
There was a total match between the coagglutination
test and the PCR method for serotyping of H. influenzae.  But
PCR capsular genotyping was more useful to distinguish
different capsular serotypes (one of type f) and capsule-
deficient mutants of type b strains - b- strains (none was
found in this study).
Serotype distribution in patients with RTI from all age
groups showed that NTHi strains were the most commonly
found isolates - 96.5%. Only two strains isolated from
mucosal respiratory infections were type b (2.6%) and 1 was
type f (0.9%). (Fig. 5)
Overall, beta-lactamase production was detected in
19.4% of the 175 tested H. influenzae strains. â-lactamase
production was higher in children with meningitis (37.7%)
and otitis media (37.5%), but it was less in mucosal
respiratory isolates (2.3%) and sputum (13.3%) in both age
groups children and adults. (Fig. 6)
Beta-lactamase production in Hib strains has not
changed over the last 15 years in children with meningitis [3].
Fig. 1. Distribution of H. influenzae isolates (n) among
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Fig. 2. H. influenzae serotype distribution (n) from
different specimens.
Fig. 4. Gel electrophoresis of PCR products (480 bp)
for the detection of capsular type b of H. influenzae:
Lane M – 100 bp Ladder; Lane 1 – positive control;
Lane 2 – Negative strain; Lane 3 – Positive isolate from CSF;
Lane 4 – Positive isolate from blood; Lane 5 – Positive isolate
from sputum; Lane 6 – Positive isolate from nasopharyngeal
swab
Fig. 3. Gel electrophoresis of PCR products (343 bp)
for the detection of bexA gene of H. influenzae:
Lane M – 100 bp Ladder; Lane 1 – positive control;
Lane 2 – Negative strain; Lane 3 – Positive isolate from CSF;
Lane 4 – Positive isolate from blood; Lane 5 – Positive isolate
from sputum; Lane 6 – Positive isolate from nasopharyngeal
swab; Lane 7 – negative control
Fig. 5. Gel electrophoresis of PCR products (450 bp)
for the detection of capsular type f of H. influenzae:
Lane M – 100 bp Ladder; Lane 1 – positive control;
Lane 2 – Negative strain; Lane 3 – Positive isolate from
sputum  / JofIMAB; Issue: vol. 16, book 3, 2010 /  69
Fig. 6. Frequency of beta-lactamase producing H.
influenzae isolates.
CONCLUSIONS
1. H. influenzae type b is the most common serotype
among the infants and children with meningitis or other
invasive infections, aged 2 months to 5 years. Approximately
one-third of the Hib isolates were beta-lactamase producing
strains.
2. The introduction of Hib vaccine in our National
Vaccination Plan will be accompanied by reduction in both
the incidence of Hib invasive disease in children and the
incidence of beta-lactamase producing Hib strains.
3. Non-typeable H. influenzae are more common than
Hib in respiratory tract infections in both children and adults.
Hib vaccine is not useful in preventing infections caused by
non-typeable H. influenzae (NTHi) strains.
4. There is a need for continued microbiological and
epidemiological surveillance on serotype distribution of H.
influenzae and surveillance to collect data on clinical
presentations of NTHi to emphasize the importance of
immunization against this disease.
Address for correspondence:
Dr. Tomislav Kostyanev, MD
Department of Medical Microbiology, Medical University – Sofia
2, Zdrave Str., 1431 Sofia, Bulgaria
Tel.: +359 2 91 72 722; Fax: +359 2 951 53 17
E-mail: t_kostyanev@yahoo.co.uk
1. Murphy, T.F. 2003. Respiratory
infections caused by non-typeable
Haemophilus influenzae. Curr Opin Infect
Dis 16: 129-134.
2. Falla T.J., D. W. Crook, L.N. Brophy
et al. 1994. PCR for Capsular Typing of
REFERENCES:
Haemophilus influenzae. J.Clin. Microbiol.
32:2382-2386.
3. Ñå÷àíîâà Ë. Ìèêðîáèîëîãè÷åí
ïîäõîä â åòèîëîãè÷íàòà òåðàïèÿ íà
îñòðèÿ áàêòåðèàëåí ìåíèíãèò. Èíôåêòî-
ëîãèÿ. 2002. ÕÕÕ²Õ, 2: 25-28.
4. Kilian M. Haemophilus. 2007. In:
Manual of Clinical Microbiology (9th ed.)
ed by Murray P.R. et al. ASM press,
Washington, DC, USA.
Acknowledgments:
This study was supported by research grant from the Medical University of Sofia, Bulgaria (Project No.16, Contract
No.18/2009).